Prof Michiel Rienstra (University Medical Center Groningen, Groningen, NL) and Dr Gijs van Woerden (University Medical Center Groningen, Groningen, NL) discuss the results of the VIP-HF study.
The VIP-HF study examined whether an implantable loop recorder (ILR) could be used in patients with HFpEF to evaluate the incidence of sustained ventricular tachyarrhythmias.
What prompted you to conduct this study?
Can you describe the study design, selection criteria and endpoints?
What does the registry data tell us to date and should this influence clinical practice?
How long will these patients be followed in the registry?
Should your findings influence further research in HFpEF patients?
What would be your take-home messages for VIP-HF?
Recorded remotely from Groningen, 2020.
Interviewer: Mirjam Boros
Recording Editor: Natascha Wienand